Ontology highlight
ABSTRACT:
SUBMITTER: Shen J
PROVIDER: S-EPMC5761123 | biostudies-literature | 2014 Jun
REPOSITORIES: biostudies-literature
Shen Jian J Yang Jiping J Heyse Winfried W Schweitzer Harald H Nagel Norbert N Andert Doris D Zhu Chengyue C Morrison Vincent V Nemeth Gregory A GA Chen Teng-Man TM Zhao Zhicheng Z Ayers Timothy A TA Choi Yong-Mi YM
Journal of pharmaceutical analysis 20131126 3
Otamixaban is a potent (Ki=0.5 nM) fXa inhibitor currently in late-stage clinical development at Sanofi for the management of acute coronary syndrome. Being unproductive in obtaining a suitable crystal of Otamixaban, the required enantiomeric characterization has been accomplished using vibrational circular dichroism (VCD) spectroscopy. Selected by a spectrum similarity index, the calculated spectra of several higher energy conformers were found to match well with the observed spectra. The chara ...[more]